RNAscence Biotechnology presented at Singapore Health & Biomedical Congress 2024!
- Helena Baric
- Oct 19, 2024
- 1 min read
Updated: Oct 22, 2024
19th October 2024
We at RNAscence Biotechnology are honored to have been invited to present at the Singapore Health & Biomedical Congress 2024!
Thanks for the great support to co11ab Novena and Centre for Medical Technologies and Innovations (CMTi)!
Our CEO Jack Wong, General Manager Diana Chor and Chief Clinical Advisor Prof. Hong Liang Tey at the Congress.
Comments